A risk model for severe anemia to select cancer patients for primary prophylaxis with epoetin {alpha}: a prospective randomized controlled trial of the ELYPSE study group

I Ray Coquard, S Dussart, C Goillot, D Mayeur, P Debourdeau, H Ghesquieres, T Bachelot, A Le Cesne, B Anglaret, C Agostini, J. P Guastalla, L Lancry, P Biron, F Desseigne and J. Y. Blay

Annals of Oncology 20 ( 6 ): 1105 - 1112 , 2009